nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyruvic acid—SLC16A1—Methotrexate—systemic scleroderma	0.13	1	CbGbCtD
Pyruvic acid—SLC16A8—tendon—systemic scleroderma	0.0445	0.0534	CbGeAlD
Pyruvic acid—SLC16A5—tendon—systemic scleroderma	0.0348	0.0418	CbGeAlD
Pyruvic acid—PDHB—connective tissue—systemic scleroderma	0.0342	0.0411	CbGeAlD
Pyruvic acid—SLC16A6—tendon—systemic scleroderma	0.0337	0.0405	CbGeAlD
Pyruvic acid—PKM—connective tissue—systemic scleroderma	0.0326	0.0392	CbGeAlD
Pyruvic acid—PDHB—smooth muscle tissue—systemic scleroderma	0.0313	0.0376	CbGeAlD
Pyruvic acid—SLC16A4—tendon—systemic scleroderma	0.031	0.0373	CbGeAlD
Pyruvic acid—SLC16A5—lung—systemic scleroderma	0.0306	0.0367	CbGeAlD
Pyruvic acid—PC—connective tissue—systemic scleroderma	0.0301	0.0362	CbGeAlD
Pyruvic acid—PKM—smooth muscle tissue—systemic scleroderma	0.0299	0.0359	CbGeAlD
Pyruvic acid—SLC16A6—lung—systemic scleroderma	0.0296	0.0355	CbGeAlD
Pyruvic acid—PKM—skin of body—systemic scleroderma	0.0295	0.0354	CbGeAlD
Pyruvic acid—SLC16A4—lung—systemic scleroderma	0.0272	0.0327	CbGeAlD
Pyruvic acid—PC—skin of body—systemic scleroderma	0.0272	0.0327	CbGeAlD
Pyruvic acid—PDHB—digestive system—systemic scleroderma	0.0247	0.0297	CbGeAlD
Pyruvic acid—PKM—digestive system—systemic scleroderma	0.0236	0.0283	CbGeAlD
Pyruvic acid—PDHB—tendon—systemic scleroderma	0.0235	0.0282	CbGeAlD
Pyruvic acid—PKM—tendon—systemic scleroderma	0.0224	0.0269	CbGeAlD
Pyruvic acid—SLC16A3—smooth muscle tissue—systemic scleroderma	0.0221	0.0265	CbGeAlD
Pyruvic acid—PC—digestive system—systemic scleroderma	0.0218	0.0261	CbGeAlD
Pyruvic acid—PDHB—lung—systemic scleroderma	0.0206	0.0248	CbGeAlD
Pyruvic acid—PKM—lung—systemic scleroderma	0.0197	0.0236	CbGeAlD
Pyruvic acid—PC—lung—systemic scleroderma	0.0182	0.0218	CbGeAlD
Pyruvic acid—SLC16A3—digestive system—systemic scleroderma	0.0174	0.0209	CbGeAlD
Pyruvic acid—SLCO2A1—skin of body—systemic scleroderma	0.0159	0.0191	CbGeAlD
Pyruvic acid—SLC16A7—tendon—systemic scleroderma	0.0158	0.019	CbGeAlD
Pyruvic acid—ABAT—tendon—systemic scleroderma	0.0151	0.0181	CbGeAlD
Pyruvic acid—SLC16A3—lung—systemic scleroderma	0.0146	0.0175	CbGeAlD
Pyruvic acid—SLC16A7—lung—systemic scleroderma	0.0139	0.0167	CbGeAlD
Pyruvic acid—SLC16A2—lung—systemic scleroderma	0.0133	0.016	CbGeAlD
Pyruvic acid—ABAT—lung—systemic scleroderma	0.0132	0.0159	CbGeAlD
Pyruvic acid—SLCO2A1—tendon—systemic scleroderma	0.0121	0.0146	CbGeAlD
Pyruvic acid—SLCO2A1—lung—systemic scleroderma	0.0106	0.0128	CbGeAlD
Pyruvic acid—SLC16A1—digestive system—systemic scleroderma	0.0106	0.0127	CbGeAlD
Pyruvic acid—SLC16A1—tendon—systemic scleroderma	0.0101	0.0121	CbGeAlD
Pyruvic acid—SLC16A10—tendon—systemic scleroderma	0.00977	0.0117	CbGeAlD
Pyruvic acid—SLC16A1—lung—systemic scleroderma	0.00885	0.0106	CbGeAlD
Pyruvic acid—SLC16A10—lung—systemic scleroderma	0.00858	0.0103	CbGeAlD
Pyruvic acid—SLC16A8—Basigin interactions—MMP1—systemic scleroderma	0.0029	0.0789	CbGpPWpGaD
Pyruvic acid—SLC16A8—Cell surface interactions at the vascular wall—SELP—systemic scleroderma	0.00241	0.0655	CbGpPWpGaD
Pyruvic acid—PKM—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	0.00197	0.0535	CbGpPWpGaD
Pyruvic acid—SLC16A8—Cell surface interactions at the vascular wall—ITGAM—systemic scleroderma	0.00193	0.0523	CbGpPWpGaD
Pyruvic acid—SLC16A3—Basigin interactions—MMP1—systemic scleroderma	0.00187	0.0508	CbGpPWpGaD
Pyruvic acid—SLC16A3—Cell surface interactions at the vascular wall—SELP—systemic scleroderma	0.00155	0.0422	CbGpPWpGaD
Pyruvic acid—SLC16A3—Cell surface interactions at the vascular wall—ITGAM—systemic scleroderma	0.00124	0.0337	CbGpPWpGaD
Pyruvic acid—PKM—Carbohydrate metabolism—HSPG2—systemic scleroderma	0.00122	0.0331	CbGpPWpGaD
Pyruvic acid—SLC16A1—Basigin interactions—MMP1—systemic scleroderma	0.00101	0.0274	CbGpPWpGaD
Pyruvic acid—PKLR—Carbohydrate metabolism—HSPG2—systemic scleroderma	0.000983	0.0267	CbGpPWpGaD
Pyruvic acid—SLC16A8—Cell surface interactions at the vascular wall—MMP1—systemic scleroderma	0.000966	0.0262	CbGpPWpGaD
Pyruvic acid—SLC16A1—Cell surface interactions at the vascular wall—SELP—systemic scleroderma	0.000839	0.0228	CbGpPWpGaD
Pyruvic acid—PC—Carbohydrate metabolism—HSPG2—systemic scleroderma	0.000771	0.0209	CbGpPWpGaD
Pyruvic acid—SLC16A1—Cell surface interactions at the vascular wall—ITGAM—systemic scleroderma	0.00067	0.0182	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—SELP—systemic scleroderma	0.000653	0.0177	CbGpPWpGaD
Pyruvic acid—SLC16A3—Cell surface interactions at the vascular wall—MMP1—systemic scleroderma	0.000622	0.0169	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—RHOB—systemic scleroderma	0.000622	0.0169	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—RHOB—systemic scleroderma	0.00061	0.0166	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—CSK—systemic scleroderma	0.000556	0.0151	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—ITGAM—systemic scleroderma	0.000522	0.0142	CbGpPWpGaD
Pyruvic acid—PKM—Disease—SMAD7—systemic scleroderma	0.000474	0.0129	CbGpPWpGaD
Pyruvic acid—PKM—Disease—TGFBI—systemic scleroderma	0.000433	0.0118	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—SELP—systemic scleroderma	0.000421	0.0114	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—RHOB—systemic scleroderma	0.000393	0.0107	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—SMAD7—systemic scleroderma	0.000382	0.0104	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—CSK—systemic scleroderma	0.000358	0.00972	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—TGFBI—systemic scleroderma	0.000349	0.00948	CbGpPWpGaD
Pyruvic acid—PKM—Disease—HSPG2—systemic scleroderma	0.000346	0.00938	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—ITGAM—systemic scleroderma	0.000337	0.00914	CbGpPWpGaD
Pyruvic acid—SLC16A1—Cell surface interactions at the vascular wall—MMP1—systemic scleroderma	0.000336	0.00912	CbGpPWpGaD
Pyruvic acid—PKM—Disease—CSK—systemic scleroderma	0.000334	0.00906	CbGpPWpGaD
Pyruvic acid—PKM—Disease—CD247—systemic scleroderma	0.000314	0.00852	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—HSPG2—systemic scleroderma	0.000308	0.00836	CbGpPWpGaD
Pyruvic acid—PC—Disease—SMAD7—systemic scleroderma	0.0003	0.00814	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—HSPG2—systemic scleroderma	0.000289	0.00786	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—HSPG2—systemic scleroderma	0.000279	0.00756	CbGpPWpGaD
Pyruvic acid—PC—Disease—TGFBI—systemic scleroderma	0.000274	0.00744	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—CSK—systemic scleroderma	0.000269	0.00731	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—MMP1—systemic scleroderma	0.000262	0.00711	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—CD247—systemic scleroderma	0.000253	0.00687	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—HSPG2—systemic scleroderma	0.000233	0.00633	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—CTGF—systemic scleroderma	0.000233	0.00633	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—HSPG2—systemic scleroderma	0.000233	0.00633	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—SELP—systemic scleroderma	0.000227	0.00618	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—CTGF—systemic scleroderma	0.000219	0.00596	CbGpPWpGaD
Pyruvic acid—PC—Disease—HSPG2—systemic scleroderma	0.000219	0.00594	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—RHOB—systemic scleroderma	0.000212	0.00577	CbGpPWpGaD
Pyruvic acid—PC—Disease—CSK—systemic scleroderma	0.000211	0.00573	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—MMP2—systemic scleroderma	0.000207	0.00561	CbGpPWpGaD
Pyruvic acid—PC—Disease—CD247—systemic scleroderma	0.000198	0.00539	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—HSPG2—systemic scleroderma	0.000198	0.00539	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—CSK—systemic scleroderma	0.000193	0.00525	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—NOS3—systemic scleroderma	0.00019	0.00515	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—HSPG2—systemic scleroderma	0.000183	0.00497	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—ITGAM—systemic scleroderma	0.000182	0.00494	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—CTGF—systemic scleroderma	0.000177	0.0048	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—CTGF—systemic scleroderma	0.000177	0.0048	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—MMP1—systemic scleroderma	0.000169	0.00458	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—MMP9—systemic scleroderma	0.000155	0.00422	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—CTGF—systemic scleroderma	0.00015	0.00408	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—HSPG2—systemic scleroderma	0.00015	0.00408	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—CTGF—systemic scleroderma	0.000139	0.00377	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—TGFB1—systemic scleroderma	0.000128	0.00347	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—TGFB1—systemic scleroderma	0.000125	0.00341	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—NOS3—systemic scleroderma	0.000122	0.00332	CbGpPWpGaD
Pyruvic acid—PKM—Disease—NOS3—systemic scleroderma	0.000114	0.0031	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—CTGF—systemic scleroderma	0.000114	0.00309	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—NOS3—systemic scleroderma	0.000102	0.00276	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—NOS3—systemic scleroderma	9.55e-05	0.00259	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—NOS3—systemic scleroderma	9.19e-05	0.0025	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—MMP1—systemic scleroderma	9.11e-05	0.00247	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—HSPG2—systemic scleroderma	8.12e-05	0.0022	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—TGFB1—systemic scleroderma	8.09e-05	0.0022	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—NOS3—systemic scleroderma	7.69e-05	0.00209	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—NOS3—systemic scleroderma	7.69e-05	0.00209	CbGpPWpGaD
Pyruvic acid—PKM—Disease—TGFB1—systemic scleroderma	7.54e-05	0.00205	CbGpPWpGaD
Pyruvic acid—PC—Disease—NOS3—systemic scleroderma	7.21e-05	0.00196	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—NOS3—systemic scleroderma	6.6e-05	0.00179	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—NOS3—systemic scleroderma	6.54e-05	0.00178	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—CTGF—systemic scleroderma	6.15e-05	0.00167	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—TGFB1—systemic scleroderma	6.08e-05	0.00165	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—NOS3—systemic scleroderma	6.04e-05	0.00164	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—NOS3—systemic scleroderma	4.96e-05	0.00135	CbGpPWpGaD
Pyruvic acid—PC—Disease—TGFB1—systemic scleroderma	4.77e-05	0.00129	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—TGFB1—systemic scleroderma	4.37e-05	0.00119	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—NOS3—systemic scleroderma	2.68e-05	0.000727	CbGpPWpGaD
